For the Inventor, By the Inventor

Enter assignee name

Zug, Switzerland

Sucampo Ag

USPTO Granted Patents = 59

CIPO Patents = 10

EPO Patents = 27

Trademarks = 3

Forward Citations = 349

Loading Chart...

Loading Chart...

26 inventors (with patents filed for the assignee):

Ryuji Ueno (57 out of 151 patents)

Ryu Hirata (9 out of 13 patents)

Yasuhiro Harada (7 out of 8 patents)

4. Tatsuya Matsukawa (5 out of 12 patents)

5. Kazuhiro Masuzaki (4 out of 7 patents)

6. Tsuyoshi Habe (4 out of 5 patents)

7. John Cuppoletti (3 out of 13 patents)

8. Junichi Kawasaki (2 out of 2 patents)

9. Yoshie Nishimura (2 out of 2 patents)

10. Yukiko Hashitera (2 out of 3 patents)

11. Myra L Patchen (2 out of 2 patents)

12. Sachiko Kuno (2 out of 8 patents)

13. Robert Gurny (1 out of 21 patents)

14. Michael Möller (1 out of 3 patents)

15. Noriyuki Yamamoto (1 out of 2 patents)

Core Competencies:

Pharmaceutical Composition

Prostaglandin Compounds

Ophthalmic Solution

Fatty Acid Derivative

Chloride Channel Opener

Macrolide Compounds

Anti-Constipation Composition

Stem Cell Growth Modulation

Gastrointestinal Disorders

Tumor Treatment

Central Nervous System Disorders

Mucositis Treatment

59 patents: Sort by Forward Citations

1. 11534404 - Multilayer beads for pharmaceutical use (2022-12-27),

2. 10561649 - Pharmaceutical combination of opioid and prostaglandin compound (2020-02-18),

3. 9254326 - Pharmaceutical composition comprising 11-deoxy-prostaglandin compound and method for stabilizing the compound (2016-02-09),

4. 9242950 - Method for preparing a fatty acid derivative (2016-01-26),

5. 9084815 - Method for treating damage induced by an anti-tumor agent, treating mucositis and treating tumor (2015-07-21),

6. 8969324 - Pharmaceutical composition comprising 11-deoxy-prostaglandin compound and method for stabilizing the compound (2015-03-03),

7. 8962688 - Method for the treatment of gastrointestinal disorders (2015-02-24),

8. 8889735 - Method for treating asthenopia (2014-11-18),

9. 8871752 - Method for modulating stem cell growth (2014-10-28),

10. 8853268 - Ophthalmic solution (2014-10-07),

11. 8835571 - Fatty acid derivative-polymer conjugate (2014-09-16),

12. 8748481 - Method for treating gastrointestinal disorder (2014-06-10),

13. 8748454 - Anti-constipation composition (2014-06-10),

14. 8669284 - Pharmaceutical composition comprising a bi-cyclic compound and method for stabilizing the bi-cyclic compound (2014-03-11),

15. 8609729 - Method for treating macular degeneration (2013-12-17),

Sucampo AG is a global biopharmaceutical company that develops and commercializes innovative medicines to treat rare diseases and conditions. With a focus on gastroenterology, ophthalmology, and oncology, Sucampo is dedicated to improving the health and well-being of patients worldwide. They strive to make a meaningful impact through their research, development, and commercialization efforts in order to provide patients with effective treatment options.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

59 Patents

#15 in Zug

#245 in Switzerland

#11,959 in the World

Zug, Switzerland

Sucampo Ag

Forward Citations = 349

26 inventors:

Ryuji Ueno (57 out of 151 patents)

Ryu Hirata (9 out of 13 patents)

Yasuhiro Harada (7 out of 8 patents)

4. Tatsuya Matsukawa (5 out of 12 patents)

5. Kazuhiro Masuzaki (4 out of 7 patents)

Please report any incorrect information to support@idiyas.com

Loading…